We have previously demonstrated that human rIL-12 alone can augment th
e development of cytotoxic activity in stimulated CD8(+) T cells. The
present study was undertaken to examine the interactions of rIL-7 and
rIL-12 on human peripheral blood T cell activation and CTL differentia
tion. Purified T lymphocytes were pulsed overnight with immobilized al
pha-CD3 and then cultured for 3 additional days with IL-7 and/or IL-12
. The combination of IL-7 and IL-12 synergistically enhanced the proli
feration of either fresh CD3(+) T cells or an IL-2-dependent CD4(+) T
cell line, Kit-225-K6. This synergy was seen on both subsets of T cell
s; however, CD8(+) T cells were usually more responsive to IL-7 and IL
-12 at lower concentrations than were CD4(+) T cells. Furthermore, the
se cytokines additively/synergistically augmented the cytotoxic activi
ty of CD8(+) T cells. Abs to IL-2 and IL-2R alpha blocked the synergis
tic effect on proliferation of CD4(+) T cells, but had a minimal effec
t on the synergistic response of the proliferative and cytotoxic activ
ity of CD8(+) T cells. Examination of the effects of IL-7 and IL-12 on
the expression of IL-12 receptor on T cells revealed an increase in t
he subunit of IL-12R by IL-7 as determined by flow cytometric analysis
. We analyzed the effects on IFN-gamma production by CD8(+) T cells an
d found that IL-7 alone did not induce detectable levels of IFN-gamma
production but together with IL-12 it synergistically enhanced the pro
duction of IFN-gamma We also found that IFN-gamma was probably not req
uired for enhanced CTL activity of CD8(+) T cells, because Ab to human
IFN-gamma did not block additive/synergistic effects of either cytoki
ne. The synergistic stimulatory activity of IL-7 and IL-12 may be of s
ignificance in vivo and may provide an alternative mechanism of stimul
ating T cells for use in immunotherapy.